Andre Nel, M.D., Ph.D.
Director of Research, CNSI; Distinguished Professor of Medicine; Chief of NanoMedicine; Director UC CEIN Nanosafety Center; Associate Editor ACS Nano
Andre Nel is a Distinguished Professor of Medicine and is Founder and Chief of the Division of Nanomedicine. In addition, he is the Director of the University of California’s Center for Environmental Implications of Nanotechnology (UC CEIN), a $48 million National Science Foundation (NSF) and Environmental Protection Agency (EPA) funded multidisciplinary and multi-institutional center for nanosafety implementation in the US. He also directs a National Cancer Institute (NCI) funded Center to study development of new nanoparticle drug delivery systems for the treatment of pancreas cancer, and previously directed the National Institutes of Health (NIH) funded Center for Nanobiology and Predictive Toxicology which focuses on human inhalation toxicology. Dr. Nel received the Harry Truman Lectureship award from Sandia National laboratories in 2012. Under his leadership, UC CEIN received the 2013 Governor’s Economic and Environmental Leadership Award (GEELA) in California. In 2014 he served on the President’s Council of Advisors on Science and Technology (PCAST) panel reviewing and providing recommendations for the future of the National Nanotechnology Initiative (NNI). Dr. Nel has represented the NIH and NNI in cooperative research agreements with Japan, Chinese Academy of Sciences, and Russia. He is an Honorary Foreign Professor in the Chinese Academy of Sciences, and have served as a member of a distinguished NSF panel that produced a comprehensive US Government Science Report and vision for US nanotechnology research in 2011-2020. Dr. Nel serves as Associate Editor of ACS Nano, an internationally recognized journal.